SELLAS Life Sciences Group, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-31. The offering totals $9.2M, of which $9.2M was reported sold. Industry: Biotechnology.
Showing 25 of 36 people.
| Name | Role | Location |
|---|---|---|
| Robert L Van Nostrand | Director | New York, NY |
| John L Varian | Director | New York, NY |
| Jane M Wasman | Director | New York, NY |
| Barbara A Wood | Executive Officer | New York, NY |
| Jane Van Wasman | Director | New York, NY |
| Angelos M Stergiou | Director | New York, NY |
| Angelos M Stergiou | Executive Officer | New York, NY |
| David A Scheinberg | Director | New York, NY |
| John T Burns | Executive Officer | New York, NY |
| John Van Varian | Director | New York, NY |
| Robert Van Nostrand | Director | New York, NY |
| Katherine Bach Kalin | Director | New York, NY |
| Thomas J Knapp | Executive Officer | Bethesda, MD |
| Steven A Kriegsman | Director | Los Angeles, CA |
| Sanford J Hillsberg | Director | Los Angeles, CA |
| Mary Ann Gray | Director | San Ramon, CA |
| Richard L Chin | Director | San Ramon, CA |
| Irving M Einhorn | Director | San Ramon, CA |
| Stephen M Galliker | Director | San Ramon, CA |
| Mark W Schwartz | Director | San Ramon, CA |
| Mark W Schwartz | Executive Officer | San Ramon, CA |
| Bijan W Nejadnik | Executive Officer | San Ramon, CA |
| Rudolph L Nisi | Director | San Ramon, CA |
| Mark W Schwartz, Ph.D. | Director | San Ramon, CA |
| Mark W Schwartz, Ph.D. | Executive Officer | San Ramon, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-03-29 | D | $18.4M | $18.4M |
| 2016-07-26 | D | $9.1M | $9.1M |
| 2016-05-24 | D | $24.0M | $24.0M |
| 2014-01-22 | D | — | — |